Slørdahl TS - Search Results

1

Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival.

Roseth Aass K, Nedal TMV, Anshushaug Bouma S, Tryggestad SS, Haukås E, Slørdahl TS, Waage A, Standal T, Mjelle R. Roseth Aass K, et al. Among authors: slordahl ts. Br J Cancer. 2023 Feb;128(4):656-664. doi: 10.1038/s41416-022-02065-1. Epub 2022 Nov 29. Br J Cancer. 2023. PMID: 36446884 Free PMC article.

2

[A man in his 60's with chest pain with chest pain and functional dyspnea].

Slørdahl TS, Amundsen BH, Størkersen O, Stensæth KH, Slette MK, Wiseth R, Grenne B. Slørdahl TS, et al. Tidsskr Nor Laegeforen. 2014 Nov 25;134(22):2167-71. doi: 10.4045/tidsskr.14.0538. eCollection 2014 Nov. Tidsskr Nor Laegeforen. 2014. PMID: 25423983 Free article. Norwegian. No abstract available.

3

[Månedens billede].

Slørdahl TS, Wader KF, Berntsen EM. Slørdahl TS, et al. Ugeskr Laeger. 2014 Sep 15;176(38):V65728. Ugeskr Laeger. 2014. PMID: 25294202 Free article. Danish. No abstract available.

4

Mn2+ regulates myeloma cell adhesion differently than the proadhesive cytokines HGF, IGF-1, and SDF-1alpha.

Slørdahl TS, Hov H, Holt RU, Baykov V, Syversen T, Sundan A, Waage A, Børset M. Slørdahl TS, et al. Eur J Haematol. 2008 Dec;81(6):437-47. doi: 10.1111/j.1600-0609.2008.01148.x. Epub 2008 Sep 4. Eur J Haematol. 2008. PMID: 18774952

5

Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.

Slørdahl TS, Denayer T, Moen SH, Standal T, Børset M, Ververken C, Rø TB. Slørdahl TS, et al. Eur J Haematol. 2013 Nov;91(5):399-410. doi: 10.1111/ejh.12185. Epub 2013 Sep 16. Eur J Haematol. 2013. PMID: 23952536

6

Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients.

Rampa C, Tian E, Våtsveen TK, Buene G, Slørdahl TS, Børset M, Waage A, Sundan A. Rampa C, et al. Among authors: slordahl ts. Biomark Res. 2014 Apr 9;2(1):8. doi: 10.1186/2050-7771-2-8. Biomark Res. 2014. PMID: 24716444 Free PMC article.

7

The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.

Slørdahl TS, Abdollahi P, Vandsemb EN, Rampa C, Misund K, Baranowska KA, Westhrin M, Waage A, Rø TB, Børset M. Slørdahl TS, et al. Oncotarget. 2016 May 10;7(19):27295-306. doi: 10.18632/oncotarget.8422. Oncotarget. 2016. PMID: 27036022 Free PMC article.

8

PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients.

Sponaas AM, Yang R, Rustad EH, Standal T, Thoresen AS, Dao Vo C, Waage A, Slørdahl TS, Børset M, Sundan A. Sponaas AM, et al. Among authors: slordahl ts. Oncotarget. 2018 Aug 10;9(62):32024-32035. doi: 10.18632/oncotarget.25882. eCollection 2018 Aug 10. Oncotarget. 2018. PMID: 30174794 Free PMC article.

9

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.

Yang R, Elsaadi S, Misund K, Abdollahi P, Vandsemb EN, Moen SH, Kusnierczyk A, Slupphaug G, Standal T, Waage A, Slørdahl TS, Rø TB, Rustad E, Sundan A, Hay C, Cooper Z, Schuller AG, Woessner R, Borodovsky A, Menu E, Børset M, Sponaas AM. Yang R, et al. Among authors: slordahl ts. J Immunother Cancer. 2020 May;8(1):e000610. doi: 10.1136/jitc-2020-000610. J Immunother Cancer. 2020. PMID: 32409420 Free PMC article.

10

Monoclonal immunoglobulins promote bone loss in multiple myeloma.

Westhrin M, Kovcic V, Zhang Z, Moen SH, Nedal TMV, Bondt A, Holst S, Misund K, Buene G, Sundan A, Waage A, Slørdahl TS, Wuhrer M, Standal T. Westhrin M, et al. Among authors: slordahl ts. Blood. 2020 Dec 3;136(23):2656-2666. doi: 10.1182/blood.2020006045. Blood. 2020. PMID: 32575115 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page